Medical Properties Trust, Inc.

As of June 30, 2026, Medical Properties Trust, Inc. carries a market capitalization of 54.50B, placing it among publicly traded companies globally. Its enterprise value stands at 218.83B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medical Properties Trust, Inc.'s next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Medical Properties Trust, Inc. has 596.79M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.07, and the price-to-book ratio stands at 0.69.

As of June 30, 2026, Medical Properties Trust, Inc. trades at an EV/EBITDA multiple of 17.62 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 12.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 29.49 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 218.83B versus a market cap of 54.50B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Medical Properties Trust, Inc. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 217.80, indicating elevated leverage, while an interest coverage ratio of 1.77 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. posted a negative return on equity (ROE) of -0.65, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.20, reflecting losses generated across the asset base. The company generates approximately 148.09M in revenue per employee across its workforce of 120.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. recorded an income tax benefit of -58.83M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -566.10M and -527.38M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 21, 2026, Medical Properties Trust, Inc.'s stock has declined approximately 44.57% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. generated 17.81B in revenue and converted that into -527.38M in net income, yielding earnings per share of -0.85. EBITDA reached 12.42B, while operating income came in at 10.08B.

As of June 30, 2026, Medical Properties Trust, Inc. holds 6.93B in cash and equivalents against 171.23B in total debt, resulting in a net debt position of 162.63B. Total book value stands at 78.60B, with working capital of 8.09B providing operational flexibility.

Medical Properties Trust, Inc. produced 3.96B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. posted a gross margin of 96.11, reflecting its pricing power and cost economics. The operating margin of 56.61 and net profit margin of -2.96 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. paid dividends of 6.01 per share. The dividend payout ratio of -739.94 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 7.24, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.40, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Medical Properties Trust, Inc. shareholders.

As of June 30, 2026, Medical Properties Trust, Inc. has an Altman Z-Score of 0.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.